nicotinamide mononucleotide has been researched along with Peripheral Nerve Injury in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, R; Carpi, FM; Coleman, MP; Conforti, L; Di Stefano, M; Gilley, J; Janeckova, L; Loreto, A; Magni, G; Marangoni, M; Meng, W; Mori, V; Nascimento-Ferreira, I; Orsomando, G; Patrick, J; Pucciarelli, S; Ribchester, RR; Rossi, F; Sagasti, A; Tickle, J; Vargas, ME; Webster, JR; Worrell, LA | 1 |
1 other study(ies) available for nicotinamide mononucleotide and Peripheral Nerve Injury
Article | Year |
---|---|
A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration.
Topics: Amidohydrolases; Animals; Axons; Bacterial Proteins; Mice; Nerve Degeneration; Nicotinamide Mononucleotide; Nicotinamide-Nucleotide Adenylyltransferase; Peripheral Nerve Injuries | 2015 |